ECCO Essential Requirements for Quality Cancer Care: Prostate cancer

Maurizio Brausi; Peter Hoskin; Elisabeth Andritsch; Ian Banks; Marc Beishon; Helen Boyle; Maurizio Colecchia; Roberto Delgado-Bolton; Michael Höckel; Kay Leonard; József Lövey; Pablo Maroto; Ken Mastris; Rui Medeiros; Peter Naredi; Raymond Oyen; Theo de Reijke; Peter Selby; Tiina Saarto; Riccardo Valdagni; Alberto Costa; Philip Poortmans

doi:10.1016/j.critrevonc.2019.102861

ECCO Essential Requirements for Quality Cancer Care: Prostate cancer

Crit Rev Oncol Hematol. 2020 Apr:148:102861. doi: 10.1016/j.critrevonc.2019.102861. Epub 2020 Jan 7.

Authors

Maurizio Brausi¹, Peter Hoskin², Elisabeth Andritsch³, Ian Banks⁴, Marc Beishon⁵, Helen Boyle⁶, Maurizio Colecchia⁷, Roberto Delgado-Bolton⁸, Michael Höckel⁹, Kay Leonard¹⁰, József Lövey¹¹, Pablo Maroto¹², Ken Mastris¹³, Rui Medeiros¹⁴, Peter Naredi¹⁵, Raymond Oyen¹⁶, Theo de Reijke¹⁷, Peter Selby¹⁸, Tiina Saarto¹⁹, Riccardo Valdagni²⁰, Alberto Costa²¹, Philip Poortmans²²

Affiliations

¹ European Association of Urology; Department of Urology, B. Ramazzini Hospital, Carpi-Modena, Italy.
² European Society for Radiotherapy and Oncology (ESTRO); Mount Vernon Cancer Centre; University of Manchester, Manchester, United Kingdom.
³ International Psycho-Oncology Society (IPOS); Clinical Department of Oncology, University Medical Centre of Internal Medicine, Medical University of Graz, Graz, Austria.
⁴ European Cancer Organisation Patient Advisory Committee (ECCO PAC); European Men's Health Forum, Belgium.
⁵ Cancer World, European School of Oncology (ESO), Milan, Italy. Electronic address: marcbeishon@icloud.com.
⁶ International Society of Geriatric Oncology (SIOG); Department of Medical Oncology, Centre Léon-Bérard, Lyon, France.
⁷ European Society of Pathology (ESP); Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
⁸ European Association for Nuclear Medicine (EANM); Department of Diagnostic Imaging (Radiology) and Nuclear Medicine, San Pedro Hospital and Centre for Biomedical Research of La Rioja (CIBIR), University of La Rioja, Logroño, La Rioja, Spain.
⁹ European Society of Oncology Pharmacy (ESOP); Kliniken Kassel, Gesundheit Nordhessen Holding, Kassel, Germany.
¹⁰ European Oncology Nursing Society (EONS); Saint Luke's Radiation Oncology Centre, St James's Hospital, Dublin, Ireland.
¹¹ Organisation of European Cancer Institutes (OECI); National Institute of Oncology, Budapest, Hungary.
¹² European Organisation for Research and Treatment of Cancer (EORTC); Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
¹³ European Cancer Organisation Patient Advisory Committee (ECCO PAC); Europa Uomo.
¹⁴ Association of European Cancer Leagues (ECL); Portuguese Cancer League, Instituto Portugues de Oncologia, Porto, Portugal.
¹⁵ European Cancer Organisation (ECCO); Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
¹⁶ European Society of Radiology (ESR); Department of Radiology, KU Leuven, Leuven, Belgium.
¹⁷ European Society of Surgical Oncology (ESSO); Department of Urology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
¹⁸ European Cancer Concord (ECC); Leeds Institute of Cancer and Pathology, University of Leeds; St James' University Hospital, Leeds, United Kingdom.
¹⁹ European Association for Palliative Care (EAPC); Palliative Care Center, Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland.
²⁰ European School of Oncology (ESO); Prostate Cancer Programme and Department of Radiation Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
²¹ European School of Oncology (ESO), Milan, Italy.
²² European Cancer Organisation (ECCO).

PMID: 32151466
DOI: 10.1016/j.critrevonc.2019.102861

Abstract

Background: ECCO Essential Requirements for Quality Cancer Care (ERQCC) are written by experts representing all disciplines involved in cancer care in Europe. They give oncology teams, patients, policymakers and managers an overview of essential care throughout the patient journey.

Prostate cancer: Prostate cancer is the second most common male cancer and has a wide variation in outcomes in Europe. It has complex diagnosis and treatment challenges, and is a major healthcare burden. Care must only be a carried out in prostate/urology cancer units or centres that have a core multidisciplinary team (MDT) and an extended team of health professionals. Such units are far from universal in European countries. To meet European aspirations for comprehensive cancer control, healthcare organisations must consider the requirements in this paper, paying particular attention to multidisciplinarity and patient-centred pathways from diagnosis, to treatment, to survivorship.

Keywords: Centres; Multidisciplinary; Pathways; Prostate cancer; Quality; Units.

Publication types

Review

MeSH terms

Delivery of Health Care*
Europe
Humans
Male
Medical Oncology
Patient Care Team
Prostatic Neoplasms*
Quality of Health Care*